Clinical Oncology: Case Reports

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Benita Wolf Author

Subjects of specialization
cancer, cancer oncology, Carcinogenesis

Affiliation
Medical Oncology Service, Department of Oncology, Lausanne University Hospital and University of Lausanne, Switzerland

Biography

Dr. Benita Wolf is working as scientist and professor at Medical Oncology Service, Department of Oncology, Lausanne University Hospital and University of Lausanne, Switzerland. The author has specalization in cancer, cancer oncology, chemotherapy, Carcinogenesis, Chemotherapy


Publications

Case Report Open Access

Successful Treatment with Rituximab of Sjögren’s Syndrome-Associated Organizing Pneumonia in a Patient Treated with PD-L1 Blockade for Ovarian Cancer

Author(s):

Angela Orcurto, Karim Abdelhamid, Claire Perrinjaquet, Benita Wolf, Cecile Daccord, Stephanie Viguet-Carrin, Stefan Zimmermann, George Coukos and Denis Comte

As the use of immune checkpoint inhibitors in cancer therapy increases across a wide range of tumor types, rarer toxicities including rheumatologic immune adverse events are reported with increasing frequency. We describe the case of an ovarian cancer patient treated with durvalumab, who developed an organizing pneumonia, proved to be related to a preexisting but previously unknown asymptomatic Sjögren’s syndrome, confirmed by a positive antibody (anti-SSA and anti-SSB) panel. While resistant to corticosteroids, was ultimately successfully treated with the B-cell depleting antibody rituximab with no impact on the anticancer therapy efficacy. This case shows that patients with preexisting autoimmune diseases should not be systematically excluded from potentially life-saving an... view more»

Abstract HTML PDF



Google Scholars / Researchers Sites

GET THE APP